Last reviewed · How we verify
Plaque disclosing tablets
At a glance
| Generic name | Plaque disclosing tablets |
|---|---|
| Also known as | Plaque disclosing agent |
| Sponsor | Aga Khan University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Plaque Control Efficacy Between Interdental Brushes Versus Dental Floss (NA)
- Evaluation of Oral Plaque Removal Utilizing an Adjunct Enzyme Pre-rinse (PHASE2)
- A Comparison of Three Different Modalities in Improving Oral Hygiene (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Plaque disclosing tablets CI brief — competitive landscape report
- Plaque disclosing tablets updates RSS · CI watch RSS
- Aga Khan University portfolio CI